Schools Adopt Face Recognition in the Name of Fighting Covid
By Gregory Barber,
Wired
| 11. 03. 2020
IN JUNE, THE school board in Rio Rancho, New Mexico, was facing a series of votes on the budget for an elaborate and expensive reopening plan. Among the big-ticket items was a tablet designed to screen students and staff for fevers. The devices were sold by a company named OneScreen, which supplies schools with technology including “smart” whiteboards and attendance apps. But this spring, it had pivoted. Its new product, called GoSafe, could scan foreheads for elevated temperatures and detect when students aren’t wearing masks. It also came with a bonus: “top-of-the-line” facial recognition, as a local vendor described it to the school board.
District officials considered this a selling point. The tablets were pricey—$161,000 for 71 devices—even amid the district’s bulk orders of hand sanitizer and protective equipment. But they would get kids through school doors more efficiently than handheld thermometers. The facial recognition tech offered another benefit: The money would not necessarily go to waste as soon as there was a Covid-19 vaccine. The district could use the devices for other things, like taking attendance or preventing intruders...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...